13F reference period
Q2 2026
Security Snapshot
Oscar Health, Inc. - Class A Common Stock, $0.00001 par value per share (OSCR) Institutional Ownership
CUSIP: 687793109
13F Institutional Holders and Ownership History from Q1 2021 to Q3 2026
Institutions Reporting
402
Shares (Excl. Options)
197.94M
Full value: 197,940,932 · shares · 30 Jun 2026Price
$28.52
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Symbol
- OSCR on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 197,940,932
- Total 13F value
- $5,646,505,114
- Portfolio coverage rank
- 0.01%
- Share change
- +23,693,535
- Value change
- +$784,157,614
- Number of holders
- 402
- Shares outstanding
- 310,127,694
- SEC-reported price per share
- $30.84
- Insider filing price
- $30.84
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- OSCR - Oscar Health, Inc. - Class A Common Stock, $0.00001 par value per share is tracked under CUSIP 687793109.
- 402 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 330 to 402 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$2B
Full value: $2,002,983,681 · USD · 31 Mar 2026.$5.65B
Full value: $5,646,505,114 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 402 institutions filings for Q2 2026.
Security key
687793109
13F reference period
Q2 2026
13F holders
402
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
OSCR full holder history
Oscar Health, Inc. SEC filings
Oscar Health, Inc. company facts
Oscar Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 687793109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
OSCR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Thrive Capital Partners III, L.P. | 12% | $1,202,315,450 | 37,525,451 | Joshua Kushner | 18 Sep 2026 | |||
| BlackRock, Inc. | 6.4% | $298,910,284 | 13,941,711 | BlackRock, Inc. | 30 Jun 2025 | |||
| JPMORGAN CHASE & CO | 4.5% | -32% | $143,092,346 | -$55,508,727 | 9,950,789 | -28% | JPMORGAN CHASE & CO. | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. | 3.7% | $157,535,536 | 8,322,004 | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 | |||
| Dragoneer Investment Group, LLC | 0.3% | $11,426,220 | 657,435 | Marc Stad | 31 Dec 2025 |
As of 30 Jun 2026,
402
institutional investors reported holding
shares of
Oscar Health, Inc. - Class A Common Stock, $0.00001 par value per share (OSCR).
This represents
64%
of the company’s total
outstanding shares.
197.94M
Full value: 197,940,932 · shares · 30 Jun 2026310.13M
Full value: 310,127,694 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.6% | 20,587,428 | +19% | 0.01% | $587,153,449 |
| T. Rowe Price Investment Management, Inc. | 4.2% | 13,035,486 | +12% | 0.24% | $371,773,000 |
| D. E. Shaw & Co., Inc. | 4.1% | 12,643,617 | +131% | 0.22% | $360,595,957 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6% | 11,029,424 | +4.6% | 0.01% | $314,559,172 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 10,579,437 | -1.8% | 0.01% | $301,725,543 |
| AMERICAN CENTURY COMPANIES INC | 2.9% | 9,055,242 | +29% | 0.11% | $258,255,502 |
| JANE STREET GROUP, LLC | 2.1% | 6,365,039 | +119% | 0.12% | $181,530,912 |
| Thrive Capital Management, LLC | 2% | 6,343,617 | 0% | 4.7% | $180,919,957 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 5,819,186 | +16% | 0.01% | $165,994,311 |
| STATE STREET CORP | 1.9% | 5,801,351 | +10% | 0% | $165,454,531 |
| FMR LLC | 1.6% | 4,998,523 | +317% | 0.01% | $142,557,861 |
| CITADEL ADVISORS LLC | 1.4% | 4,229,552 | +22% | 0.07% | $120,626,823 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 4,035,689 | +72% | 0.09% | $115,097,850 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 3,571,731 | -15% | 0.02% | $101,885,043 |
| BIT Capital GmbH | 1.1% | 3,417,957 | -46% | 3.3% | $97,480,134 |
| RENAISSANCE TECHNOLOGIES LLC | 1.1% | 3,284,500 | 0.13% | $93,673,940 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1% | 3,255,724 | +70% | 0.01% | $92,855,000 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.98% | 3,025,316 | +22% | 0.31% | $86,282,012 |
| GLYNN CAPITAL MANAGEMENT LLC | 0.83% | 2,575,828 | -0.62% | 20% | $73,462,615 |
| GOLDMAN SACHS GROUP INC | 0.74% | 2,289,557 | +56% | 0.01% | $65,298,165 |
| NORTHERN TRUST CORP | 0.71% | 2,211,209 | +18% | 0.01% | $63,063,680 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.68% | 2,119,863 | +12% | 0.01% | $60,458,493 |
| MORGAN STANLEY | 0.68% | 2,114,280 | -37% | 0% | $60,299,272 |
| Nuveen, LLC | 0.57% | 1,770,745 | +34% | 0.01% | $50,501,648 |
| BNP PARIBAS FINANCIAL MARKETS | 0.55% | 1,706,196 | 0% | 0.03% | $48,660,710 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Headline period
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 9,460,473 | $291,850,632 | +$11,574,374 | $30.84 | 76 |
| 2026 Q2 | 197,940,932 | $5,646,505,114 | +$784,157,614 | $28.52 | 402 |
| 2026 Q1 | 174,341,215 | $2,002,983,681 | -$1,616,757 | $11.47 | 330 |
| 2025 Q4 | 168,569,629 | $2,422,621,495 | +$226,271,692 | $14.37 | 342 |
| 2025 Q3 | 149,792,205 | $2,835,618,710 | -$426,363,004 | $18.93 | 335 |
| 2025 Q2 | 168,548,889 | $3,611,647,706 | -$289,634,922 | $21.44 | 323 |
| 2025 Q1 | 186,598,634 | $2,446,656,406 | -$110,044,429 | $13.11 | 285 |
| 2024 Q4 | 194,956,941 | $2,621,590,374 | +$146,853,067 | $13.44 | 257 |
| 2024 Q3 | 178,386,882 | $3,782,103,219 | +$110,762,194 | $21.21 | 279 |
| 2024 Q2 | 172,745,011 | $2,733,174,271 | +$252,278,335 | $15.82 | 258 |
| 2024 Q1 | 156,903,935 | $2,334,180,594 | +$193,138,229 | $14.87 | 215 |
| 2023 Q4 | 150,724,824 | $1,379,131,654 | -$3,785,138 | $9.15 | 186 |
| 2023 Q3 | 147,067,613 | $819,530,306 | -$7,326,284 | $5.57 | 175 |
| 2023 Q2 | 148,010,019 | $1,192,835,277 | +$5,911,074 | $8.06 | 161 |
| 2023 Q1 | 147,482,265 | $964,531,497 | +$66,794,321 | $6.54 | 130 |
| 2022 Q4 | 139,544,348 | $343,274,000 | -$14,475,084 | $2.46 | 129 |
| 2022 Q3 | 146,909,762 | $733,091,997 | +$22,710,896 | $4.99 | 129 |
| 2022 Q2 | 142,413,972 | $605,294,235 | -$91,989,720 | $4.25 | 126 |
| 2022 Q1 | 143,850,142 | $1,434,295,239 | +$18,060,433 | $9.97 | 122 |
| 2021 Q4 | 130,976,699 | $1,028,199,597 | +$32,022,110 | $7.85 | 107 |
| 2021 Q3 | 125,835,387 | $2,183,281,915 | -$105,326,121 | $17.39 | 87 |
| 2021 Q2 | 128,494,559 | $2,769,676,759 | -$63,986,538 | $21.50 | 75 |
| 2021 Q1 | 136,426,375 | $3,646,678,745 | +$3,332,048,743 | $26.88 | 88 |